HomeGUD • TSE
add
Knight Therapeutics Inc
Previous close
$6.43
Day range
$6.32 - $6.45
Year range
$5.09 - $6.55
Market cap
631.81M CAD
Avg Volume
69.65K
P/E ratio
5,711.71
Dividend yield
-
Primary exchange
TSE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 107.36M | 12.33% |
Operating expense | 48.50M | 13.20% |
Net income | -12.62M | -549.95% |
Net profit margin | -11.76 | -479.31% |
Earnings per share | -0.09 | -411.60% |
EBITDA | 8.47M | -52.05% |
Effective tax rate | 19.14% | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 116.42M | -26.07% |
Total assets | 1.04B | 9.79% |
Total liabilities | 274.89M | 50.57% |
Total equity | 763.06M | — |
Shares outstanding | 99.65M | — |
Price to book | 0.84 | — |
Return on assets | -0.90% | — |
Return on capital | -1.07% | — |
Cash Flow
Net change in cash
| (CAD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -12.62M | -549.95% |
Cash from operations | 20.25M | 1,964.83% |
Cash from investing | -101.29M | -961.86% |
Cash from financing | 50.81M | 547.21% |
Net change in cash | -34.34M | -1,593.24% |
Free cash flow | 19.41M | 216.15% |
About
Knight Therapeutics Inc. is a Canadian public specialty pharmaceutical company based in Montreal, Quebec that focuses on acquiring or in-licensing innovative pharmaceutical products for the Canadian and select international markets. It is listed on the Toronto Stock Exchange, with a market capitalization of $1.02 billion as of August 2019. Wikipedia
Founded
2014
Headquarters
Website
Employees
745
